Can magnets boost your memory? new study aims to find out
NCT ID NCT07398833
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 2 times
Summary
This study compares two types of brain stimulation—electrical and magnetic—to see which one better improves working memory. 102 healthy adults will perform memory tasks while receiving stimulation, and their brain activity will be recorded with EEG. The goal is to find out if magnetic stimulation is more comfortable and effective at reaching deep brain areas.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- transcranial alternating magnetic stimulation (tAMS)
- What this could lead to
- If successful, this could point toward a more comfortable and effective way to boost memory using magnetic fields.
- What could go wrong
- This is an early study in healthy people, not patients. It may not show clear benefits, and results may not apply to memory disorders.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Not a phased trial
Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.
- Participants
-
About 102 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Apr 2026
An estimate. Start dates often move.
- Expected to finish
-
Sep 2028
An estimate. End dates often move.
- Lead sponsor
-
Other sponsor
The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
18 to 50 years
- Sex
-
Anyone
- Healthy volunteers
-
Accepted
You do not need to have the condition being studied to take part.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: * Written, voluntary, and informed consent to participate in the study * Fluent French speaker (task instructions are provided in French) * Normal or corrected-to-normal vision using contact lenses only Non inclusion Criteria: * Individuals deprived of liberty by law * Individuals under legal guardianship or curatorship * Pregnant or breastfeeding women * Presence of metallic implants in the head, implanted electronic devices, or any other metallic object that cannot be removed for the experiment (e.g. dental fillings) * History of neurological or psychiatric disorders according to the DSM-5 (Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition) * History of pathology or chronic disease affecting memory or attention * Drug or alcohol consumption within the previous 24 hours
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Healthy are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a protein powder with creatine and fiber boost everyday Well-Being?
- Green tech or hidden stress? bus Drivers' hearts monitored behind the wheel
- Shout it out: can growls and screams raise pain tolerance?
- Scientists probe why brain stimulation works for some and not others
- Tiny doses, big questions: how does the body handle this prodrug?
- First human test of CM583: can this biologic pass the safety check?